A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

Saba S. Shaikh*, Priya U. Kumthekar, Nisha A. Mohindra

*Corresponding author for this work

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)235-237
Number of pages3
JournalJournal of Neuro-Oncology
Volume144
Issue number1
DOIs
StatePublished - Aug 15 2019

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this